Abstract
The clot-busting drug tissue plasminogen activator (tPA) is currently the only FDA-approved therapy for acute stroke. However, increasing evidence suggests that tPA can also contribute to excitotoxic neuronal damage in animal models of stroke.
MeSH terms
-
Animals
-
Disease Models, Animal
-
Neurons / drug effects*
-
Neurons / pathology
-
Receptors, N-Methyl-D-Aspartate / metabolism
-
Stroke / drug therapy*
-
Stroke / pathology
-
Tissue Plasminogen Activator / therapeutic use*
Substances
-
Receptors, N-Methyl-D-Aspartate
-
Tissue Plasminogen Activator